Page last updated: 2024-10-26

doxepin and Liver Diseases

doxepin has been researched along with Liver Diseases in 2 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Liver Diseases: Pathological processes of the LIVER.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meng, X1
Gu, Z1
Xie, X1
Su, Y1
Zhang, X1
Ma, H1
Guo, Y1
Liu, X1
Cheng, Y1
Chang, Y1
Bao, J1
Keegan, AD1

Other Studies

2 other studies available for doxepin and Liver Diseases

ArticleYear
Acid sphingomyelinase mediates the noise-induced liver disorder in mice.
    Clinical and experimental pharmacology & physiology, 2019, Volume: 46, Issue:6

    Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Ceramides; Doxepin; Fibrosis;

2019
Doxepin-induced recurrent acute hepatitis.
    Australian and New Zealand journal of medicine, 1993, Volume: 23, Issue:5

    Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Doxepin; Humans; Liver Diseases; Male; Middle

1993